{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/ulcerative-colitis/background-information/extra-intestinal-manifestations/","result":{"pageContext":{"chapter":{"id":"488ac85b-91d2-5298-9127-69ae212ceeac","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations","depth":2,"htmlHeader":"<!-- begin field a19eebf5-fd76-45b1-b744-806a5e9f72db --><h2>What are the extra-intestinal manifestations?</h2><!-- end field a19eebf5-fd76-45b1-b744-806a5e9f72db -->","summary":"","htmlStringContent":"<!-- begin item 8fafcefa-3dca-4e48-aa8f-e9d4afde9342 --><!-- begin field b402b5db-07ad-441d-ab2e-a0ce7f2b4620 --><p><strong>About 30% of people with ulcerative colitis have extra-intestinal manifestations affecting other organs, and they may be the first presentation of inflammatory bowel disease </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Ford, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Harbord, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Oliveira, 2017</a>]<strong>.</strong></p><ul><li><strong>Extra-intestinal manifestations related to disease activity include:</strong><ul><li>Pauci-articular arthritis<ul><li>This affects fewer than five large joints, such as the ankles, knees, hips, wrists, elbows, and shoulders.</li><li>It is usually asymmetric, acute, and self-limiting (lasting for weeks rather than months), and joints tend not to be permanently damaged.</li><li>There is often associated enthesitis (inflammation where a tendon attaches to a bone), tenosynovitis (inflammation of a tendon and its sheath), or dactylitis (inflammation of an entire finger or toe).</li></ul></li><li>Erythema nodosum<ul><li>Raised tender, red or violet subcutaneous nodules, 1–5 cm in diameter.</li><li>Usually on the anterior tibial area or extensor surfaces of the legs or arms, and may be associated with arthralgia and fatigue.</li></ul></li><li>Aphthous mouth ulcers<ul><li>Painful, clearly defined, round or ovoid, shallow ulcers of the smooth surfaces of the mouth and underside of the tongue. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/aphthous-ulcer/\">Aphthous ulcer</a> for more information.</li></ul></li><li>Episcleritis<ul><li>Red eye with injected sclera and conjunctiva.</li><li>May be painless or painful, itching or burning. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/red-eye/\">Red eye</a> for more information.</li></ul></li><li>Metabolic bone disease (osteopenia, osteoporosis, osteomalacia)<ul><li>Osteoporosis occurs in up to 30% of men and women with inflammatory bowel disease. There is an increased risk of osteoporosis in people with ulcerative colitis compared with the general population. Contributing factors include young age at diagnosis of colitis, corticosteroid treatment, smoking status, low physical activity, recurrent active disease, and nutritional deficiencies. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/osteoporosis-prevention-of-fragility-fractures/\">Osteoporosis - prevention of fragility fractures</a> for more information.</li><li>Osteopenia is a precursor of osteoporosis causing reduced bone mineral density.</li><li>Osteomalacia is a condition of defective bone matrix mineralization resulting from vitamin D malabsorption, which can occur in ulcerative colitis. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-children/\">Vitamin D deficiency in children</a> and <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/\">Vitamin D deficiency in adults - treatment and prevention</a> for more information.</li></ul></li><li>Venous thromboembolism (VTE)<ul><li>The risk of VTE is at least 2-fold higher in people with ulcerative colitis than in the general population, and the risk is greatest during active disease. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/deep-vein-thrombosis/\">Deep vein thrombosis</a> for more information.</li></ul></li></ul></li><li><strong>Extra-intestinal manifestations not related to disease activity include:</strong><ul><li>Axial arthritis<ul><li>This affects the sacroiliac joint (sacroiliitis) or spine (spondylitis), causing buttock and back pain. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/ankylosing-spondylitis/\">Ankylosing spondylitis</a> for more information.</li></ul></li><li>Polyarticular arthritis<ul><li>This affects five or more joints, such as the small joints of the hands.</li><li>It is usually symmetrical and persistent, and it damages the affected joints.</li></ul></li><li>Pyoderma gangrenosum<ul><li>Single or multiple erythematous papules or pustules develop into deep violaceous ulcers typically 2–20 cm diameter containing sterile pus unless they are secondarily infected.</li><li>Occurs anywhere, most commonly on the shins and adjacent to stomas, and often at the site of previous trauma.</li></ul></li><li>Uveitis (also known as 'iritis' or 'iridocyclitis').<ul><li>Uveitis is usually bilateral, with an insidious onset and chronic course.</li><li>It presents as a painful red eye, with injected conjunctiva, blurred vision, photophobia, and headache. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/red-eye/\">Red eye</a> and <a class=\"topic-reference external-reference\" href=\"/topics/uveitis/\">Uveitis</a> for more information.</li></ul></li><li>Hepatobiliary conditions such as primary sclerosing cholangitis, pericholangitis, steatosis, autoimmune hepatitis, cirrhosis, and gallstones.<ul><li>Hepatobiliary conditions may be a complication of ulcerative colitis or result from adverse effects of drug treatments. They often present as an incidental finding of abnormal liver function tests, rather than as biliary symptoms. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/gallstones/\">Gallstones</a>, <a class=\"topic-reference external-reference\" href=\"/topics/jaundice-in-adults/\">Jaundice in adults</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/non-alcoholic-fatty-liver-disease-nafld/\">Non-alcoholic fatty liver disease (NAFLD)</a> for more information.</li><li>Primary sclerosing cholangitis can progress to cirrhosis and increases the risk of cancers of the bile duct, colon, and rectum.</li></ul></li><li>Others<ul><li>Rare extra-intestinal manifestations of inflammatory bowel disease include bronchiectasis, bronchitis, hyperhomocysteinemia, pancreatitis, and renal stones. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/bronchiectasis/\">Bronchiectasis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/pancreatitis-acute/\">Pancreatitis - acute</a>, <a class=\"topic-reference external-reference\" href=\"/topics/pancreatitis-chronic/\">Pancreatitis - chronic</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/renal-or-ureteric-colic-acute/\">Renal or ureteric colic - acute</a> for more information.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Larsen et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Navaneethan and Shen, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Mowat et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Burisch, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Rosen, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Fell, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Harbord, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Turner, 2018a</a>]</p><!-- end field b402b5db-07ad-441d-ab2e-a0ce7f2b4620 --><!-- end item 8fafcefa-3dca-4e48-aa8f-e9d4afde9342 -->","topic":{"id":"34aee656-b482-5065-8656-44c487e4e347","topicId":"6a63bd87-53c1-487d-8426-773cffdb4c43","topicName":"Ulcerative colitis","slug":"ulcerative-colitis","lastRevised":"Last revised in April 2020","chapters":[{"id":"8ec19c69-a796-514b-a267-91bd57a12fe3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dc4de3c1-9955-536e-9789-a900261d2189","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"04875f8c-29b3-5d60-8e5c-06930138cfc4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"04f00df3-2de5-5c61-bb95-25edda5f885b","slug":"changes","fullItemName":"Changes"},{"id":"12402ddb-2eb9-589e-a1c3-24d50e2538f8","slug":"update","fullItemName":"Update"}]},{"id":"2c186889-f3c1-5094-b0ce-0b9a81f46d61","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"36a3da73-b00f-5ee2-bfd9-33293a674904","slug":"goals","fullItemName":"Goals"},{"id":"5c86e0bc-3476-59dd-b120-519602968645","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3ab8e65e-aac9-54a1-abb3-9185c76c6004","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0efa89a1-51f7-59ff-95ce-94faac48f8a5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a2b17331-6cfc-56eb-84c5-433f78f4364c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"01a70081-193a-5d75-92fb-45f84ee7b317","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"87cfff6e-6028-5fda-aee6-4473268cac77","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"116a07eb-6832-5d49-aa1d-497f7c0684a9","slug":"definition","fullItemName":"Definition"},{"id":"fef2143b-1809-58f3-bdf9-0d73710d89ae","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"9c9a2e21-7e98-5876-945d-ec18ebfaee62","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5102ad12-cd60-5939-ad9a-00d4dafca9b0","slug":"complications","fullItemName":"Complications"},{"id":"488ac85b-91d2-5298-9127-69ae212ceeac","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations"},{"id":"9ff94ba6-78d6-5ed0-9cda-f234b24236d7","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2149059a-c90f-50e5-9fa2-227a488d2004","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"40b81845-1ebc-55b2-b825-05a3d62e3cc4","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"0102b680-c790-5c87-aaec-ea332f5fc9b2","slug":"investigations","fullItemName":"Investigations"},{"id":"2ea841c6-272f-5b4b-a165-499ec0228439","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"468c6dcc-e9f2-5154-9f2b-30d7dafb7415","fullItemName":"Management","slug":"management","subChapters":[{"id":"6a9b8b90-a418-5e1b-9442-ac55ee36430f","slug":"suspected-ulcerative-colitis","fullItemName":"Scenario: Suspected ulcerative colitis"},{"id":"6d8002d3-29fe-5bfd-ba03-7ce0173636e4","slug":"confirmed-ulcerative-colitis","fullItemName":"Scenario: Confirmed ulcerative colitis"},{"id":"56868b16-5233-5bb8-9412-d2d9bfafe8d9","slug":"fertility-pregnancy-breastfeeding-with-ulcerative-colitis","fullItemName":"Scenario: Fertility, pregnancy, and breastfeeding with ulcerative colitis"},{"id":"7708c2de-0c02-5b83-a354-70788b3dc297","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"010b277d-6575-5cdc-b995-6fc7d89fb745","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a8ed7157-985a-58a5-b567-571fa748a73b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a1164542-c6ec-5b63-bfee-efc59657c778","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"568370d3-2e5b-55a4-ae50-2eeeb5ca3234","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"df1aecf8-eeb0-5069-965e-21ccf0690af8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"889198a1-b809-54b2-b803-3ee02e6f45af","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a290d39a-e351-5dec-9607-943a59e60b2e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"916d81a4-ae1e-529e-936f-183b4514ba9f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"87cfff6e-6028-5fda-aee6-4473268cac77","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}